Navigation Links
Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities
Date:12/8/2009

NEW YORK, Dec. 8 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Bulk Paclitaxel - A Global Update of Market Trends & Opportunities

http://www.reportlinker.com/p0164226/Bulk-Paclitaxel---A-Global-Update-of-Market-Trends--Opportunities.html

World bulk paclitaxel market stands enthused by the effervescent levels of research and development. With market participants injecting resources into developing unique paclitaxel formulations, emergence of new disease indications is expected to result in expanded market opportunities in the medium to long run. For instance, development of paclitaxel-coated coronary stents will help further improve the use and sales of paclitaxel. With patent expiries leading to the influx of generic forms of paclitaxel, competition is expected to intensify and result in price reductions.

These and other market data and trends are presented in "Bulk Paclitaxel: A Global Update of Market Trends & Opportunities" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

BULK PACLITAXEL BMR-1026

CONTENTS

1. METHODOLOGY 1

Study Reliability and Reporting Limitations 1

Disclaimers 2

Quantitative Techniques & Reporting Level 3

2. INDUSTRY OVERVIEW 3

Paclitaxel - Leading from the Front 3

US Market - Magnificently Outdistancing Others 4

Cancer Blockbusters - Facing the Brunt 4

A Sunrise Opportunity 4

BMS' Reign Comes to an End 4

Exploring New Avenues 5

Falling Prices - Boon for The Customers, Bane for The Companies 6

All the Strangle for Peanuts? 6

Factors Affecting the Market 6

Paclitaxel Versus Abraxane 7

3. OUTLOOK 7

Competitive Scenario 8

Cancer Generics - A Time for Optimism 8

The US Piazza 8

4. PRODUCT FACTS 9

5. RESEARCH AND DEVELOPMENT 10

Angiotech Unfurls New Dimensions for Paclitaxel 10

Clinical Research Favors Paclitaxel for Breast Cancer Treatment 11

American BioScience' Nab Technology Unveils Higher Tissue

Penetration Potential 11

Naturol Develops Unique Extraction Technology for Producing

Paclitaxel from Canadian Yew 11

Ivax Corp.'s Xorane Revolutionizes the Delivery of Paclitaxel 12

6. CORPORATE DEVELOPMENTS 13

Sonus to Merge with OncoGenex 13

Acusphere Signs Licensing Deal with Cephalon 13

Sonus Terminates TOCOSOL Paclitaxel Development Program 13

Eagle Pharmaceuticals to Develop and Market Tocosol Paclitaxel 13

Pliva Lachema Receives ANDA for Paclitaxel Injection 14

Cell Therapeutics Receives EMEA Acceptance 14

Abraxis Wins Approval for ABRAXANE in Korea 14

Boston Scientific Obtains Approval for TAXUS® Liberte® from

Health Canada 14

Cell Therapeutics Renames Xyotax as Opaxio 14

Dabur Launches Cancer Drug 14

Hospira Takes Over Mayne Pharma 14

Protherics to Acquire MacroMed 15

Abraxis Acquires Arizona Production Facility 15

Indena Inks Worldwide License Agreement with Spectrum Pharma 15

Bioxel Bags Major Paclitaxel Order 16

Bioxel Enters into Supply Agreement 16

Bioxel Bags Paclitaxel Supply Contract 16

Indena Establishes New Plant to Produce Synthetic Paclitaxel 16

Abraxis Selects Korean Green Cross to Market ABRAXANE® 17

Abraxis Grants License to Biocon for Marketing ABRAXANE® 17

Bioxel Registers Docetaxel with US FDA 17

Bayer Quashes TOCOSOL Paclitaxel License with Sonus 17

Abraxis' ABRAXANE Convinces European CHMP 18

Abraxis Receives Approval for ABRAXANE in Australia 18

Eurocor Receives CE Mark 18

SuperGen Divests Certain Drugs to Intas 18

Abraxis Plans Separation of Oncology Business 18

Dabur Introduces Nanoxel 19

7. MAJOR PLAYERS 19

Abraxis BioScience, Inc. (USA) 19

Bristol-Myers Squibb Co. (USA) 19

Hospira, Inc. (USA) 20

Indena S.p.A. (Italy) 20

OncoGenex Pharmaceuticals, Inc. (USA) 20

Teva Pharmaceuticals USA, Inc. (USA) 20

8. MARKET ANALYTICS 21

9. THE UNITED STATES 22

Rising Demand for Paclitaxel 23

Alarming Growth of Breast Cancer 23

Clinical Research Favors Paclitaxel for Breast Cancer Treatment 23

Paclitaxel - An Important Element 23

Corporate Talk 23

Drug-Eluting Stents - Marching Ahead 24

10. REST OF WORLD 25

Europe 25

European Market Overview 25

European Market Battling Cost- Containment Woes 25

Efforts to Improve the Scenario and their Effect on

Paclitaxel Market 26

China 26

Chinese Government Strategizing to Save Paclitaxel Reserves 26

EXHIBITS

Table 1: Global Bulk Paclitaxel Market by Region for the Period

2007-2015 (Sales in Kilograms)

Table 2: Percentage Breakdown (Volume Sales) of Global Bulk

Paclitaxel Market by Region for the Years 2008 & 2012

Table 3: Global Bulk Paclitaxel Market by Region for the

Period 2007-2015 (Sales in US$ Million)

Table 4: Percentage Breakdown (Dollar Sales) of Global Bulk

Paclitaxel Market by Region for the Years 2008 & 2012

Table 5: Bulk Paclitaxel Market in the US: 2007-2015 (Sales in

Kilograms)

Table 6: Bulk Paclitaxel Market in the US: 2007-2015 (Sales

in US$ Million)

Table 7: Bulk Paclitaxel Market in Rest of World: 2007-2015

(Sales in Kilograms)

Table 8: Bulk Paclitaxel Market in Rest of World: 2007-2015

(Sales in US$ Million)

COMPANIES PROFILED

To order this report:

Pharmaceutical Industry: Bulk Paclitaxel - A Global Update of Market Trends & Opportunities

More Market Research Report


Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker


'/>"/>
SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... , March 27, 2017 LightIntegra Technology Inc. ... William "Bill" Dubiel as President and Chief Executive Officer ... to the Board of Directors of LightIntegra. Paul ... Chairman of LightIntegra. "This is the ... and Chief Executive Officer. We,ve selected a very strong ...
(Date:3/27/2017)... and VANCOUVER, British Columbia, March 27, 2017 /PRNewswire/ ... (the "Company" or "Sophiris"), a clinical late-stage biopharmaceutical ... patients with urological diseases, today reported fourth quarter ... corporate highlights. Key Corporate Highlights: ... Development for Localized Prostate Cancer. During 2016, the ...
(Date:3/27/2017)... , March 27, 2017   Pulmatrix, Inc . (NASDAQ: ... to address serious pulmonary diseases, today announced that it has ... cystic fibrosis and asthma to its Scientific Advisory Board ... Richard B. Moss , MD, former chief of ... the Cystic Fibrosis Center at Stanford University, and ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... 28, 2017 , ... Via Oncology, the leading provider of ... free, public-facing tool for analyzing the costs of various drug regimens in cancer ... to patients, providers, insurers and pharmaceutical companies about the estimated costs of treatment ...
(Date:3/28/2017)... ... March 28, 2017 , ... Alert Sentry Group LLC., a leader in ... Response Systems), the iSAFE and the iSAFE Plus. These iSAFE products are the most ... kind, the iSAFE and iSAFE Plus offer direct GPS Location and two-way calling with ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... the University of Pittsburgh Medical Center (UPMC) will acquire QuikClot® Bleeding Control Kits® ... The program, developed in association with efforts by the American College of Surgeons, ...
(Date:3/28/2017)... ... 2017 , ... WHO: , Dr. Paul Thomas; Dr. Brian Hooker; Dr. Judy ... PhD scientists will speak to the press on behalf of over 200 doctors, scientists, ... vaccine safety commission. , WHERE: , Zenger Room, National Press Club, 529 14th ...
(Date:3/28/2017)... ... 28, 2017 , ... Usually, the impending arrival of warmer weather means the ... about a double chin, this means more anxiety than elation. The cosmetic dermatology experts ... people, a double chin is undesirable,” Dr. Goldman said, “but it seems doubly so ...
Breaking Medicine News(10 mins):